论文部分内容阅读
目的:观察依达拉奉对急性脑出血的疗效。方法:将138例急性脑出血患者随机分为治疗组和对照组,治疗组在常规治疗的基础上,给予依达拉奉30mg加生理盐水100ml静脉滴注,每日2次,分别于治疗前及治疗2周后采用NIHSS量表评分及疗效评定。结果:治疗组神经功能缺损评分明显低于对照组(P<0.05);治疗组的治愈率和显效率显著高于对照组(P<0.05)。结论:急性期应用依达拉奉可明显促进脑出血患者的神经功能康复,提高脑出血患者的临床疗效。
Objective: To observe the effect of edaravone on acute cerebral hemorrhage. Methods: 138 patients with acute cerebral hemorrhage were randomly divided into treatment group and control group. On the basis of conventional treatment, the treatment group was given edaravone 30mg plus 100ml normal saline intravenously 2 times a day before treatment And 2 weeks after treatment with NIHSS scale score and efficacy evaluation. Results: The score of neurological deficit in the treatment group was significantly lower than that in the control group (P <0.05). The cure rate and markedly effective rate in the treatment group were significantly higher than those in the control group (P <0.05). Conclusion: The application of edaravone in acute phase can obviously promote the neurological rehabilitation of patients with intracerebral hemorrhage and improve the clinical curative effect in patients with intracerebral hemorrhage.